XML 51 R37.htm IDEA: XBRL DOCUMENT v3.20.4
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Oct. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Allocated Share-based compensation expense disclosure
The impact on our results for share-based compensation was as follows:

Years Ended October 31,
202020192018
(in millions)
Cost of products and services$21 $18 $16 
Research and development
Selling, general and administrative54 47 48 
Total share-based compensation expense$84 $72 $71 
Share-based compensation arrangement by share-based payment award fair value assumptions and methodology schedule
The following assumptions were used to estimate the fair value of awards granted.

 Years Ended October 31,
 202020192018
LTPP:   
Volatility of Agilent shares23%22%21%
Volatility of selected peer-company shares
15%-44%
15%-66%
14%-66%
Pair-wise correlation with selected peers29%30%32%
Post-vest restriction discount for all executive awards5.3%5.0%4.8%
Summary of stock option award activity
The following table summarizes employee stock option award activity of our employees and directors for 2020.

Options
Outstanding
Weighted
Average
Exercise Price
 (in thousands) 
Outstanding at October 31, 20191,445 $36 
Exercised(575)$34 
Outstanding at October 31, 2020870 $37 
Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range
The options outstanding and exercisable for equity share-based payment awards at October 31, 2020 were as follows:

 Options OutstandingOptions Exercisable
Range of
Exercise Prices
Number
Outstanding
Weighted
Average
Remaining
Contractual
Life
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
Number
Exercisable
Weighted
Average
Remaining
Contractual
Life
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
 (in thousands)(in years) (in thousands)(in thousands)(in years) (in thousands)
$25.01 - $30.00
228 1.7$27 $17,192 228 1.7$27 $17,192 
$30.01 - $40.00
121 3.1$39 7,586 121 3.1$39 7,586 
$40.01- over
521 4.0$41 31,883 521 4.0$41 31,883 
870 3.3$37 $56,661 870 3.3$37 $56,661 
Schedule of intrinsic value of options exercised and the fair value of options granted
The following table summarizes the aggregate intrinsic value of options exercised in 2020, 2019 and 2018:

Aggregate
Intrinsic Value
Weighted
Average
Exercise
Price
 (in thousands) 
Options exercised in fiscal 2018$28,417 $32 
Options exercised in fiscal 2019$24,409 $33 
Options exercised in fiscal 2020$30,481 $34 
Non-vested award activity disclosure
The following table summarizes non-vested award activity in 2020 primarily for our LTPP and restricted stock unit awards.
SharesWeighted
Average
Grant Price
 (in thousands) 
Non-vested at October 31, 20193,173 $60 
Granted1,091 $79 
Vested(1,629)$52 
Forfeited(115)$68 
Change in LTPP shares in the year due to exceeding performance targets298 $47 
Non-vested at October 31, 20202,818 $70